Nephrotoxicity induced by repeated cycles of oxaliplatin in a Japanese colorectal cancer patient with moderate renal impairment

Hitoshi Kawazoe, Hiroki Sugishita, Shinichi Watanabe, Akihiro Tanaka, Jyunko Morioka, Katsuya Suemaru, Yuji Watanabe, Kanji Kawachi, Hiroaki Araki

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

There have so far been few reports of the pharmacokinetics of oxaliplatin in patients with renal impairment. This report describes the nephrotoxicity induced by repeated cycles of oxaliplatin in a Japanese colorectal cancer patient with moderate renal impairment (creatinine clearance (Ccr): 20-30 mL/min). The patient was a 77-year-old male who had chronic renal impairment and received the modified FOLFOX6 repeated every 2 weeks. In cycle 8, the blood concentration of oxaliplatin (66 mg/m2) was measured as the platinum level to confirm the patient's safety. The serum ultrafiltrate concentrations of platinum were 800, 1,000, 300, <200, and <200 ng/mL at 1, 2, 3 hr, 1 week, and 2 weeks after the start of infusion, respectively, which were closely comparable with the population pharmacokinetic data in Japanese patients with normal renal function. On the other hand, the serum creatinine value was gradually increased after cycle 6, resulting in a decrease of Ccr. The mean Ccr during day 1-59 and day 240-299 were significantly different at 26.5±2.8 (mean±SD) and 9.6±1.9 mL/min, respectively. Consequently, the chemotherapy showed a complete response after 10 cycles, but the patient got dialysis on day 311. In conclusion, the repeated cycles of oxaliplatin cumulatively damaged the renal function in a Japanese patient with a moderate renal impairment.

Original languageEnglish
Pages (from-to)1153-1157
Number of pages5
JournalJapanese Journal of Cancer and Chemotherapy
Volume37
Issue number6
Publication statusPublished - 2010 Jan 1
Externally publishedYes

Fingerprint

oxaliplatin
Colorectal Neoplasms
Kidney
Creatinine
Platinum
Pharmacokinetics
Patient Safety
Serum
Dialysis

Keywords

  • Oxaliplatin
  • Pharmacokinetics
  • Toxicity

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Nephrotoxicity induced by repeated cycles of oxaliplatin in a Japanese colorectal cancer patient with moderate renal impairment. / Kawazoe, Hitoshi; Sugishita, Hiroki; Watanabe, Shinichi; Tanaka, Akihiro; Morioka, Jyunko; Suemaru, Katsuya; Watanabe, Yuji; Kawachi, Kanji; Araki, Hiroaki.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 37, No. 6, 01.01.2010, p. 1153-1157.

Research output: Contribution to journalArticle

Kawazoe, H, Sugishita, H, Watanabe, S, Tanaka, A, Morioka, J, Suemaru, K, Watanabe, Y, Kawachi, K & Araki, H 2010, 'Nephrotoxicity induced by repeated cycles of oxaliplatin in a Japanese colorectal cancer patient with moderate renal impairment', Japanese Journal of Cancer and Chemotherapy, vol. 37, no. 6, pp. 1153-1157.
Kawazoe, Hitoshi ; Sugishita, Hiroki ; Watanabe, Shinichi ; Tanaka, Akihiro ; Morioka, Jyunko ; Suemaru, Katsuya ; Watanabe, Yuji ; Kawachi, Kanji ; Araki, Hiroaki. / Nephrotoxicity induced by repeated cycles of oxaliplatin in a Japanese colorectal cancer patient with moderate renal impairment. In: Japanese Journal of Cancer and Chemotherapy. 2010 ; Vol. 37, No. 6. pp. 1153-1157.
@article{0dbd3abb371b446497f34e9b893aa8a1,
title = "Nephrotoxicity induced by repeated cycles of oxaliplatin in a Japanese colorectal cancer patient with moderate renal impairment",
abstract = "There have so far been few reports of the pharmacokinetics of oxaliplatin in patients with renal impairment. This report describes the nephrotoxicity induced by repeated cycles of oxaliplatin in a Japanese colorectal cancer patient with moderate renal impairment (creatinine clearance (Ccr): 20-30 mL/min). The patient was a 77-year-old male who had chronic renal impairment and received the modified FOLFOX6 repeated every 2 weeks. In cycle 8, the blood concentration of oxaliplatin (66 mg/m2) was measured as the platinum level to confirm the patient's safety. The serum ultrafiltrate concentrations of platinum were 800, 1,000, 300, <200, and <200 ng/mL at 1, 2, 3 hr, 1 week, and 2 weeks after the start of infusion, respectively, which were closely comparable with the population pharmacokinetic data in Japanese patients with normal renal function. On the other hand, the serum creatinine value was gradually increased after cycle 6, resulting in a decrease of Ccr. The mean Ccr during day 1-59 and day 240-299 were significantly different at 26.5±2.8 (mean±SD) and 9.6±1.9 mL/min, respectively. Consequently, the chemotherapy showed a complete response after 10 cycles, but the patient got dialysis on day 311. In conclusion, the repeated cycles of oxaliplatin cumulatively damaged the renal function in a Japanese patient with a moderate renal impairment.",
keywords = "Oxaliplatin, Pharmacokinetics, Toxicity",
author = "Hitoshi Kawazoe and Hiroki Sugishita and Shinichi Watanabe and Akihiro Tanaka and Jyunko Morioka and Katsuya Suemaru and Yuji Watanabe and Kanji Kawachi and Hiroaki Araki",
year = "2010",
month = "1",
day = "1",
language = "English",
volume = "37",
pages = "1153--1157",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "6",

}

TY - JOUR

T1 - Nephrotoxicity induced by repeated cycles of oxaliplatin in a Japanese colorectal cancer patient with moderate renal impairment

AU - Kawazoe, Hitoshi

AU - Sugishita, Hiroki

AU - Watanabe, Shinichi

AU - Tanaka, Akihiro

AU - Morioka, Jyunko

AU - Suemaru, Katsuya

AU - Watanabe, Yuji

AU - Kawachi, Kanji

AU - Araki, Hiroaki

PY - 2010/1/1

Y1 - 2010/1/1

N2 - There have so far been few reports of the pharmacokinetics of oxaliplatin in patients with renal impairment. This report describes the nephrotoxicity induced by repeated cycles of oxaliplatin in a Japanese colorectal cancer patient with moderate renal impairment (creatinine clearance (Ccr): 20-30 mL/min). The patient was a 77-year-old male who had chronic renal impairment and received the modified FOLFOX6 repeated every 2 weeks. In cycle 8, the blood concentration of oxaliplatin (66 mg/m2) was measured as the platinum level to confirm the patient's safety. The serum ultrafiltrate concentrations of platinum were 800, 1,000, 300, <200, and <200 ng/mL at 1, 2, 3 hr, 1 week, and 2 weeks after the start of infusion, respectively, which were closely comparable with the population pharmacokinetic data in Japanese patients with normal renal function. On the other hand, the serum creatinine value was gradually increased after cycle 6, resulting in a decrease of Ccr. The mean Ccr during day 1-59 and day 240-299 were significantly different at 26.5±2.8 (mean±SD) and 9.6±1.9 mL/min, respectively. Consequently, the chemotherapy showed a complete response after 10 cycles, but the patient got dialysis on day 311. In conclusion, the repeated cycles of oxaliplatin cumulatively damaged the renal function in a Japanese patient with a moderate renal impairment.

AB - There have so far been few reports of the pharmacokinetics of oxaliplatin in patients with renal impairment. This report describes the nephrotoxicity induced by repeated cycles of oxaliplatin in a Japanese colorectal cancer patient with moderate renal impairment (creatinine clearance (Ccr): 20-30 mL/min). The patient was a 77-year-old male who had chronic renal impairment and received the modified FOLFOX6 repeated every 2 weeks. In cycle 8, the blood concentration of oxaliplatin (66 mg/m2) was measured as the platinum level to confirm the patient's safety. The serum ultrafiltrate concentrations of platinum were 800, 1,000, 300, <200, and <200 ng/mL at 1, 2, 3 hr, 1 week, and 2 weeks after the start of infusion, respectively, which were closely comparable with the population pharmacokinetic data in Japanese patients with normal renal function. On the other hand, the serum creatinine value was gradually increased after cycle 6, resulting in a decrease of Ccr. The mean Ccr during day 1-59 and day 240-299 were significantly different at 26.5±2.8 (mean±SD) and 9.6±1.9 mL/min, respectively. Consequently, the chemotherapy showed a complete response after 10 cycles, but the patient got dialysis on day 311. In conclusion, the repeated cycles of oxaliplatin cumulatively damaged the renal function in a Japanese patient with a moderate renal impairment.

KW - Oxaliplatin

KW - Pharmacokinetics

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=79960828844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960828844&partnerID=8YFLogxK

M3 - Article

VL - 37

SP - 1153

EP - 1157

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 6

ER -